deltatrials
Completed OBSERVATIONAL NCT02545101

An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH (SAMPLE)

A Non Interventional, Retrospective Study on Real World Usage and Treatment Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to the SIADH.

Sponsor: Otsuka Pharmaceutical Europe Ltd

Conditions Hyponatremia Syndrome of Inappropriate ADH (SIADH) Secretion
Updated 11 times since 2017 Last updated: Feb 5, 2018 Started: Nov 30, 2015 Primary completion: Apr 30, 2016 Completion: Apr 30, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Hyponatremia and Syndrome of Inappropriate ADH (SIADH) Secretion and is currently completed. Otsuka Pharmaceutical Europe Ltd leads this study, which shows 11 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Mar 2018 · 13 months · monthly snapshotCompleted~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshotCompleted~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 11 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2023 — Jul 2024 [monthly]

    Completed

  5. Dec 2022 — Jan 2023 [monthly]

    Completed

▶ Show 6 earlier versions

  1. Jan 2021 — Dec 2022 [monthly]

    Completed

  2. Jun 2018 — Jan 2021 [monthly]

    Completed

  3. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

  4. Mar 2018 — Apr 2018 [monthly]

    Completed NA

  5. Feb 2017 — Mar 2018 [monthly]

    Completed NA

  6. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Otsuka Pharmaceutical Europe Ltd
Data source: Otsuka Pharmaceutical Europe Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations